首页> 外文OA文献 >Changes in Thirst Intensity During Optimization of Heart Failure Medical Therapy by Nurses at the Outpatient Clinic.
【2h】

Changes in Thirst Intensity During Optimization of Heart Failure Medical Therapy by Nurses at the Outpatient Clinic.

机译:门诊诊所护士优化心力衰竭药物治疗过程中的口渴强度变化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Thirst can be aggravated in patients with heart failure (HF), and optimization of HF medication can have positive impact on thirst. OBJECTIVES: The aims of this study were to describe changes in thirst intensity and to determine factors associated with high thirst intensity during optimization of HF medication. METHODS AND RESULTS: Patients with HF (N = 66) who were referred to an HF clinic for up-titration of HF medication were included. Data were collected during the first visit to the clinic and at the end of the treatment program. Data were dichotomized by the median visual analog scale score for thirst, dividing patients into 2 groups: low thirst intensity (0-20 mm) and high thirst intensity (>20 mm on a visual analog scale of 0-100 mm). In total, 67% of the patients reported a higher thirst intensity after the HF up-titration program. There was no difference in thirst intensity between the patients who reached target doses and those who did not. Plasma urea level (odds ratio, 1.33; 95% confidence interval, 1.07-1.65) and fluid restriction (odds ratio, 6.25; 95% confidence interval, 1.90-20.5) were independently associated with high thirst intensity in patients with HF. CONCLUSIONS: Thirst intensity increased in two-thirds of the patients during a time period of optimization of HF medication. Fluid restriction and plasma urea levels were associated with high thirst intensity.
机译:背景:心力衰竭(HF)患者可加重口渴,优化HF药物可对口渴产生积极影响。目的:本研究的目的是描述口渴强度的变化,并确定在HF药物优化期间口渴强度高的相关因素。方法和结果:包括HF患者(N = 66),这些患者被转诊至HF诊所以进行HF药物调高。数据是在首次就诊期间和治疗方案结束时收集的。数据按口渴的视觉模拟量表中位数分为两部分,将患者分为两组:低口渴强度(0-20毫米)和高口渴强度(在0-100 mm的视觉模拟量表上> 20 mm)。总计,有67%的患者在HF滴定程序后报告口渴强度更高。达到目标剂量的患者和未达到目标剂量的患者之间的口渴强度没有差异。 HF患者的口渴强度与血浆尿素水平(比值1.33; 95%置信区间1.07-1.65)和体液限制(比值6.25; 95%置信区间1.90-20.5)相关。结论:在优化HF药物治疗期间,三分之二的患者口渴强度增加。液体限制和血浆尿素水平与高口渴强度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号